ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.068,21
0,26%
S&P 500
5.462,19
0,56%
Dow Jones
38.681,26
0,24%
Euro vs US Dollar
1,07242
0,06%
Bitcoin
66.062,77
-0,87%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) News

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANIP
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
11/06/202422h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
07/06/202400h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
06/06/202413h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
05/06/202413h59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
05/06/202400h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
04/06/202422h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
29/05/202422h30GlobeNewswire Inc.ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
24/05/202402h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
24/05/202402h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
24/05/202401h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
24/05/202401h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
24/05/202401h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
23/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
23/05/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
21/05/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
20/05/202422h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
20/05/202412h50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Kionex® SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
18/05/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
18/05/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
17/05/202422h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
16/05/202423h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
16/05/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
16/05/202422h49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
15/05/202422h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
15/05/202401h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
14/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
13/05/202423h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
10/05/202413h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIPANI Pharmaceuticals Inc
10/05/202412h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
DBI
SDXP
SDAX
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
TG
BAS
BASF
CCOM
US100
US Tech 100
NASDAQ
TSLA
Tesla
TG
CBK
Commerzbank
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
TG
NOV
Novo Nordisk
FX
EURGBP
Euro vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten